Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Finasteride is effective in stopping hair loss and promoting regrowth in most men with mild side effects.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

The normal human prostate does not significantly affect blood DHT levels.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Natural gene therapy shows promise for treating skin disorders like epidermolysis bullosa.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

The patient has frontal fibrosing alopecia (FFA).

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

SHH protein helps nerve regeneration in hypertensive rats.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

Using truncal anesthesia on the supraorbital nerve reduces pain in hair loss treatments and improves patient comfort.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Combination therapy for hair loss can improve results and reduce side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Muscles can make their own androgens, which may help muscle growth.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.